Univariable multinomial logistic regression for baseline clinical and PET metrics for HRDE subsets
Variables . | FL24 . | Early TFL . | Late TFL . | FL24 vs early TFL, P value . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
RRR . | 95% CI . | FL24 vs Ref FL, P value . | RRR . | 95% CI . | Early TFL vs Ref FL, P value . | RRR . | 95% CI . | Late TFL vs Ref FL, P value . | ||
Female | 0.93 | 0.49-1.76 | .81 | 0.68 | 0.31-1.50 | .34 | 0.64 | 0.16-2.61 | .54 | .53 |
ECOG PS >2 | 2.07 | 0.74-5.80 | .17 | 5.98 | 2.37-15.11 | <.001 | NA | _ | _ | .092 |
Stage III-IV | 2.22 | 0.76-6.42 | .14 | 1.97 | 0.58-6.71 | .28 | 0.80 | 0.16-3.92 | .78 | .88 |
Elevated LDH | 2.86 | 1.50-5.46 | .001 | 3.69 | 1.71-7.98 | <.001 | 1.50 | 0.37-6.12 | .57 | .60 |
Age >60 | 1.15 | 0.61-2.18 | .66 | 1.49 | 0.69-3.26 | .31 | 0.73 | 0.19-2.77 | .64 | .60 |
>4 nodal sites | 1.20 | 0.63-2.28 | .59 | 0.73 | 0.34-1.56 | .42 | 0.63 | 0.17-2.37 | .49 | .31 |
Hb < 120 g/L | 1.10 | 0.44-2.76 | .83 | 2.16 | 0.87-5.36 | .09 | NA | _ | _ | .28 |
Grade 3A | 0.39 | 0.05-3.06 | .37 | 3.55 | 1.25-10.07 | .02 | NA | _ | _ | .053 |
BM involvement | 1.24 | 0.58-2.63 | .58 | 2.12 | 0.84-5.35 | .11 | 0.94 | 0.16-5.73 | .95 | .36 |
Elevated B2M | 1.87 | 0.70-5.02 | .21 | 7.06 | 2.34-21.32 | <.001 | 0.80 | 0.09-7.35 | .85 | .065 |
FLIPI low (0-1) | 1.00 | Reference | .13 | 1.00 | Reference | .012 | 1.00 | Reference | .28 | .83 |
FLIPI Int (2) | 1.38 | 0.50-3.83 | 1.15 | 0.27-4.96 | 0.17 | 0.02-1.57 | ||||
FLIPI high (3-5) | 2.34 | 0.92-5.93 | 3.93 | 1.14-13.55 | 0.56 | 0.14-2.30 |
Variables . | FL24 . | Early TFL . | Late TFL . | FL24 vs early TFL, P value . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
RRR . | 95% CI . | FL24 vs Ref FL, P value . | RRR . | 95% CI . | Early TFL vs Ref FL, P value . | RRR . | 95% CI . | Late TFL vs Ref FL, P value . | ||
Female | 0.93 | 0.49-1.76 | .81 | 0.68 | 0.31-1.50 | .34 | 0.64 | 0.16-2.61 | .54 | .53 |
ECOG PS >2 | 2.07 | 0.74-5.80 | .17 | 5.98 | 2.37-15.11 | <.001 | NA | _ | _ | .092 |
Stage III-IV | 2.22 | 0.76-6.42 | .14 | 1.97 | 0.58-6.71 | .28 | 0.80 | 0.16-3.92 | .78 | .88 |
Elevated LDH | 2.86 | 1.50-5.46 | .001 | 3.69 | 1.71-7.98 | <.001 | 1.50 | 0.37-6.12 | .57 | .60 |
Age >60 | 1.15 | 0.61-2.18 | .66 | 1.49 | 0.69-3.26 | .31 | 0.73 | 0.19-2.77 | .64 | .60 |
>4 nodal sites | 1.20 | 0.63-2.28 | .59 | 0.73 | 0.34-1.56 | .42 | 0.63 | 0.17-2.37 | .49 | .31 |
Hb < 120 g/L | 1.10 | 0.44-2.76 | .83 | 2.16 | 0.87-5.36 | .09 | NA | _ | _ | .28 |
Grade 3A | 0.39 | 0.05-3.06 | .37 | 3.55 | 1.25-10.07 | .02 | NA | _ | _ | .053 |
BM involvement | 1.24 | 0.58-2.63 | .58 | 2.12 | 0.84-5.35 | .11 | 0.94 | 0.16-5.73 | .95 | .36 |
Elevated B2M | 1.87 | 0.70-5.02 | .21 | 7.06 | 2.34-21.32 | <.001 | 0.80 | 0.09-7.35 | .85 | .065 |
FLIPI low (0-1) | 1.00 | Reference | .13 | 1.00 | Reference | .012 | 1.00 | Reference | .28 | .83 |
FLIPI Int (2) | 1.38 | 0.50-3.83 | 1.15 | 0.27-4.96 | 0.17 | 0.02-1.57 | ||||
FLIPI high (3-5) | 2.34 | 0.92-5.93 | 3.93 | 1.14-13.55 | 0.56 | 0.14-2.30 |